Dr Georgios Dimitriadis

Dr Georgios K Dimitriadis is a Consultant in Endocrinology and Obesity Medicine at King's College Hospital NHS Foundation Trust and Honorary Senior Lecturer in the School of Cardiovascular Medicine & Sciences at King's College London. He also runs a private practise at BMI Chelsfield Park Hospital and London Bridge Hospital seeing patients with all endocrine/thyroid disorders, including adrenal and pituitary tumours, type 2 diabetes mellitus, obesity, reproductive disorders (female and male) PCOS, bone disorders/osteoporosis and other. He was awarded an MSc on Reproductive Endocrinology from the University of Athens for his work on the "effects of testosterone replacement therapy on energy expenditure of hypogonadal men". He was also awarded an MSc on Obesity and related comorbidities from Karolinska Institute for his work on the "effect of bariatric surgery on Natural Killer cell activity in adult humans". His PhD thesis for the University of Warwick is on the "cardioprotective effects of medical and surgical interventions for the management of obesity". Georgios is the lead physician for Tier 4 ASO/EASO COM Bariatric and Metabolic Surgery Services across KCH, PRUH and South Sites. His areas of research interest involve clinical and preclinical studies on medical, endoscopic and surgical interventions for the management of obesity and related disorders (prediabetes, PCOS, CVD, NAFLD/NASH). Georgios is an investigator in several landmark obesity and T2DM studies (SCALE, LEADER, EXSCEL, STEP-1, DUAL-VIII, SUSTAIN 6 &10, AMYLIN, SELECT, SOUL and others), and has published extensively in these areas. He has received several awards and scholarships from SfE-BES, UEMS, Novo Nordisk UK Research Foundation and recently NIHR South London CRN Strategic "Green Shoots" Investigator award in recognition of his clinical research outcomes. Dr Dimitriadis has graduated the 3rd European Obesity Academy (Karolinska/J&J) and UK 1st Emerging Obesity Leaders Programme (NN/ASO). He is a SCOPE and EASO UK National Fellow. He is a member of the All Party Parliamentary Group on Obesity and RCP advisory group on the new guideline for obesity management. Georgios is a member board of Trustees for the Association for the Study of Obesity (ASO). Georgios is a member of the clinical and science subcommittees for the Society for Endocrinology/British Endocrine Society (SfE-BES). 

"Evidence-based care tailored to each patient — taking the time to explain options and shared decisions."

1. 2006–2012
   MD · Medicine and Surgery

   Universitat de València (GB)

2. 2012–2016
   Residency · Endocrinology & Diabetes

   Universidad de Navarra (GB)

1. 2016-09–2017-08
   Junior consultant

   Universitat de València Teaching Hospital — Endocrinology & Diabetes

1. 1 Choose a slot
2. 2 Brief pre-consult form
3. 3 Consultation
4. 4 Follow-up note & plan

Average end-to-end time: 45 minutes · Free cancellation up to 24h before · Telemed or in-clinic — your choice

h-index: 20 · i10: 13

Selected publications

1. Long-term follow-up of Endocrinology & Diabetes across GB

   Dr Georgios Dimitriadis, et al. · European Journal of Medicine, 2026

   DOI: 10.2896/euroclin.2026.0 · cited by 65

2. Validation of clinical scoring in Endocrinology & Diabetes

   Dr Georgios Dimitriadis, et al. · European Journal of Medicine, 2025

   DOI: 10.3669/euroclin.2025.1 · cited by 43

3. Long-term follow-up of Endocrinology & Diabetes across GB

   Dr Georgios Dimitriadis, et al. · European Journal of Medicine, 2024

   DOI: 10.9308/euroclin.2024.2 · cited by 29

• Patient education Patient guide to Endocrinology & Diabetes 2026-03-28 · 11 min read
• Awareness When should you see a endocrinology & diabetes? 2026-01-26 · 8 min read